OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 141
- −17 vs. Q4 2021
- Portfolio value
- $6.16B
- −$1.55B (−20.1%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Owlet, Inc.69120X115 | EQUITY WRT | 220,704 | $170.0K | <0.1% | 00.0% | Unchanged | – |
| LABPLandos Biopharma, Inc. | COM | 283,217 | $418.0K | <0.1% | 00.0% | Unchanged | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 143,640 | $580.0K | <0.1% | 00.0% | Unchanged | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 27,000 | $595.0K | <0.1% | +27,000 | New | History |
| LBPHLongboard Pharmaceuticals, Inc. | COM | 113,500 | $606.0K | <0.1% | 00.0% | Unchanged | History |
| Field Trip Health Ord31656R102 | COM | 576,930 | $762.0K | <0.1% | −961,540−62.5% | Reduced | – |
| CABACabaletta Bio, Inc. | COM | 577,509 | $1.17M | <0.1% | +275,000+90.9% | Added | History |
| APTXAptinyx Inc. | COM | 538,500 | $1.22M | <0.1% | −211,000−28.2% | Reduced | History |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 1,941,219 | $1.75M | <0.1% | −28,781−1.5% | Reduced | – |
| Exscientia PLC30223G102 | ADS | 125,000 | $1.80M | <0.1% | 00.0% | Unchanged | – |
| NBPNovaBridge Biosciences | SPONSORED ADS | 111,120 | $1.80M | <0.1% | 00.0% | Unchanged | History |
| SGHTSight Sciences, Inc. | COM | 200,000 | $2.31M | <0.1% | 00.0% | Unchanged | History |
| XFORX4 Pharmaceuticals, Inc | COM | 1,373,849 | $2.40M | <0.1% | 00.0% | Unchanged | History |
| TRMLTourmaline Bio, Inc. | COM | 247,240 | $2.43M | <0.1% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 411,191 | $2.89M | <0.1% | +411,191 | New | History |
| SRPTSarepta Therapeutics, Inc. | COM | 39,100 | $3.05M | <0.1% | −19,600−33.4% | Reduced | History |
| AFIBAcutus Medical, Inc. | COM | 2,648,386 | $3.68M | 0.1% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 128,100 | $3.83M | 0.1% | +128,100 | New | History |
| TARAProtara Therapeutics, Inc. | COM STK | 830,641 | $4.25M | 0.1% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,584,845 | $4.66M | 0.1% | 00.0% | Unchanged | – |
| VORVor Biopharma Inc. | COM | 833,333 | $5.03M | 0.1% | 00.0% | Unchanged | History |
| CALCCalciMedica, Inc. | COM SHS | 4,163,347 | $5.12M | 0.1% | 00.0% | Unchanged | History |
| IMDXInsight Molecular Diagnostics Inc. | COM | 3,493,800 | $5.21M | 0.1% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,813,489 | $5.43M | 0.1% | 00.0% | Unchanged | History |
| CTMXCytomX Therapeutics, Inc. | COM | 2,124,975 | $5.67M | 0.1% | −1,089,534−33.9% | Reduced | History |
| LogicBio Therapeutics, Inc.54142F102 | COM | 8,466,783 | $5.76M | 0.1% | 00.0% | Unchanged | – |
| ALBOAlbireo Pharma, Inc. | COM | 194,000 | $5.79M | 0.1% | +194,000 | New | History |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $6.09M | 0.1% | – | – | – |
| NMTR9 Meters Biopharma, Inc. | COM | 10,275,887 | $6.16M | 0.1% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,250,953 | $6.53M | 0.1% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 2,956,124 | $6.80M | 0.1% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 670,787 | $7.02M | 0.1% | −134,254−16.7% | Reduced | History |
| SONXSonendo, Inc. | COM | 1,968,180 | $7.89M | 0.1% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 361,300 | $7.95M | 0.1% | +144,300+66.5% | Added | History |
| LENZLENZ Therapeutics, Inc. | COM | 1,565,812 | $7.99M | 0.1% | 00.0% | Unchanged | History |
| IRONDisc Medicine, Inc. | COM | 5,826,224 | $8.10M | 0.1% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 4,386,568 | $8.25M | 0.1% | 00.0% | Unchanged | History |
| Cybin Ord23256X100 | COM | 10,524,300 | $8.60M | 0.1% | 00.0% | Unchanged | – |
| DMRADamora Therapeutics, Inc. | COM | 4,090,937 | $9.00M | 0.1% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 509,949 | $9.35M | 0.2% | −25,765−4.8% | Reduced | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 111,800 | $10.0M | 0.2% | −897,900−88.9% | Reduced | – |
| Bellus Health Inc New07987C204 | COM NEW | 1,454,800 | $10.1M | 0.2% | 00.0% | Unchanged | – |
| ALXOAlx Oncology Holdings Inc | COM | 621,700 | $10.5M | 0.2% | +414,100+199.5% | Added | History |
| LUNGPulmonx Corp | COM | 435,000 | $10.8M | 0.2% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 2,087,568 | $11.1M | 0.2% | −250,006−10.7% | Reduced | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 3,791,204 | $11.3M | 0.2% | 00.0% | Unchanged | History |
| SGFYSignify Health, Inc. | CL A COM | 620,700 | $11.3M | 0.2% | +620,700 | New | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 6,943,654 | $11.4M | 0.2% | 00.0% | Unchanged | History |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $12.0M | 0.2% | – | New | – |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 2,578,174 | $12.4M | 0.2% | 00.0% | Unchanged | History |
| Danaher Corp235851409 | 5% CONV PFD B | – | $12.7M | 0.2% | – | – | – |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 208,225 | $12.9M | 0.2% | −509,032−71.0% | Reduced | History |
| NXTCNextCure, Inc. | COM | 2,711,013 | $13.2M | 0.2% | 00.0% | Unchanged | History |
| BNRBurning Rock Biotech Ltd | SPONSORED ADS | 1,452,402 | $13.5M | 0.2% | 00.0% | Unchanged | History |
| ETNB89bio, Inc. | COM | 3,658,869 | $13.8M | 0.2% | −70,573−1.9% | Reduced | History |
| AMGNAmgen Inc | Stock | 57,100 | $13.8M | 0.2% | 00.0% | Unchanged | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 406,100 | $13.8M | 0.2% | 00.0% | Unchanged | History |
| ERASErasca, Inc. | COM | 1,667,693 | $14.3M | 0.2% | 00.0% | Unchanged | History |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $14.4M | 0.2% | – | New | – |
| SYBXSynlogic, Inc. | COM | 6,029,995 | $14.5M | 0.2% | 00.0% | Unchanged | History |
| OMICSingular Genomics Systems, Inc. | COM | 2,300,792 | $14.5M | 0.2% | +196,433+9.3% | Added | History |
| DBTXDecibel Therapeutics, Inc. | COM | 4,945,192 | $15.0M | 0.2% | 00.0% | Unchanged | History |
| HARPHarpoon Therapeutics, Inc. | COM | 3,039,508 | $15.1M | 0.2% | +136,000+4.7% | Added | History |
| ILMNIllumina, Inc. | COM | 45,100 | $15.8M | 0.3% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 12,909,283 | $16.0M | 0.3% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 227,600 | $16.5M | 0.3% | +227,600 | New | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 2,583,821 | $16.6M | 0.3% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 919,249 | $16.6M | 0.3% | +333,675+57.0% | Added | History |
| GILDGilead Sciences, Inc. | Stock | 287,600 | $17.1M | 0.3% | 00.0% | Unchanged | History |
| RXSTRxSight, Inc. | COM | 1,383,500 | $17.1M | 0.3% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 1,289,280 | $17.5M | 0.3% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 2,933,941 | $17.9M | 0.3% | 00.0% | Unchanged | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 7,884,870 | $18.4M | 0.3% | 00.0% | Unchanged | – |
| MRSNMersana Therapeutics, Inc. | COM | 4,788,900 | $19.1M | 0.3% | +1,900,053+65.8% | Added | History |
| MREOMereo BioPharma Group plc | SPON ADS | 10,154,810 | $19.3M | 0.3% | – | – | History |
| JNCEJounce Therapeutics, Inc. | COM | 2,859,900 | $19.4M | 0.3% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 686,000 | $21.0M | 0.3% | +55,000+8.7% | Added | History |
| PASGPassage BIO, Inc. | COM | 7,331,999 | $22.7M | 0.4% | +369,100+5.3% | Added | History |
| IVVDInvivyd, Inc. | COM | 5,056,000 | $23.1M | 0.4% | +72,500+1.5% | Added | History |
| KDNYChinook Therapeutics, Inc. | COM | 1,418,300 | $23.2M | 0.4% | 00.0% | Unchanged | History |
| BIIBBiogen Inc. | COM | 117,900 | $24.8M | 0.4% | −112,300−48.8% | Reduced | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,224,770 | $25.1M | 0.4% | 00.0% | Unchanged | History |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 5,330,704 | $25.1M | 0.4% | +106,900+2.0% | Added | – |
| GHRSGH Research PLC | ORDINARY SHARES | 1,428,732 | $26.1M | 0.4% | 00.0% | Unchanged | History |
| ACRSAclaris Therapeutics, Inc. | COM | 1,579,900 | $27.2M | 0.4% | +594,000+60.2% | Added | History |
| SCPHscPharmaceuticals Inc. | COM | 4,797,148 | $27.2M | 0.4% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 5,694,841 | $28.4M | 0.5% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 21,642,975 | $29.7M | 0.5% | 00.0% | Unchanged | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 8,740,887 | $30.7M | 0.5% | 00.0% | Unchanged | History |
| TBPHTheravance Biopharma, Inc. | COM | 3,254,713 | $31.1M | 0.5% | −2,719,822−45.5% | Reduced | History |
| NPCENeuroPace Inc | COM | 4,012,281 | $32.9M | 0.5% | 00.0% | Unchanged | History |
| TELATELA Bio, Inc. | COM | 3,027,542 | $35.2M | 0.6% | 00.0% | Unchanged | History |
| PCVXVaxcyte, Inc. | COM | 1,513,659 | $36.6M | 0.6% | +416,959+38.0% | Added | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 4,081,592 | $36.6M | 0.6% | 00.0% | Unchanged | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,158,300 | $37.5M | 0.6% | +177,000+8.9% | Added | History |
| NSTGNS Wind Down Co., Inc. | COM | 1,157,387 | $40.2M | 0.7% | +350,287+43.4% | Added | History |
| JANXJanux Therapeutics, Inc. | COM | 2,836,386 | $40.7M | 0.7% | 00.0% | Unchanged | History |
| ABCLAbCellera Biologics Inc. | COM | 4,180,768 | $40.8M | 0.7% | 00.0% | Unchanged | History |
| EVHEvolent Health, Inc. | CL A | 1,400,000 | $45.2M | 0.7% | +462,000+49.3% | Added | History |
| KNTEKinnate Biopharma Inc. | COM | 4,043,629 | $45.5M | 0.7% | +195,700+5.1% | Added | History |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q4 2021 (28)
Positions held at the end of Q4 2021 that are gone from this filing.
| Security | Class | Shares in Q4 2021 | Value in Q4 2021 | % of portfolio in Q4 2021 | History |
|---|---|---|---|---|---|
| MRKMerck & Co., Inc. | Stock | 1,779,300 | $136.4M | 1.8% | History |
| HCAHCA Healthcare, Inc. | COM | 389,500 | $100.1M | 1.3% | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 564,300 | $71.7M | 0.9% | History |
| OSHOak Street Health, Inc. | COM | 1,290,300 | $42.8M | 0.6% | History |
| SEMSelect Medical Holdings Corp | COM | 1,233,600 | $36.3M | 0.5% | History |
| CTKBCytek Biosciences, Inc. | COM | 1,923,139 | $31.4M | 0.4% | History |
| IMGNImmunoGen, Inc. | COM | 3,868,786 | $28.7M | 0.4% | History |
| APLTApplied Therapeutics, Inc. | COM | 2,313,681 | $20.7M | 0.3% | History |
| CRISCuris Inc | COM NEW | 3,634,800 | $17.3M | 0.2% | History |
| LABStandard Biotools Inc. | COM | 3,819,348 | $15.0M | 0.2% | History |
| RXDXPrometheus Biosciences, Inc. | COM | 250,000 | $9.88M | 0.1% | History |
| CVRXCVRx, Inc. | COM | 723,055 | $8.84M | 0.1% | History |
| GOSSGossamer Bio, Inc. | COM | 683,000 | $7.72M | 0.1% | History |
| NAUTNautilus Biotechnology, Inc. | COM | 1,452,774 | $7.53M | 0.1% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 53,200 | $6.29M | 0.1% | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 1,837,500 | $5.99M | 0.1% | History |
| NRIXNurix Therapeutics, Inc. | COM | 184,468 | $5.34M | 0.1% | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 500,000 | $5.04M | 0.1% | History |
| IPSCCentury Therapeutics, Inc. | COM | 307,047 | $4.87M | 0.1% | History |
| IFRXInflaRx N.V. | COM | 875,297 | $4.17M | 0.1% | History |
| INZYInozyme Pharma, Inc. | COM | 526,600 | $3.59M | <0.1% | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 127,600 | $3.08M | <0.1% | History |
| SURFSurface Oncology, Inc. | COM | 467,945 | $2.24M | <0.1% | History |
| DRUGBright Minds Biosciences Inc. | COM | 660,600 | $2.13M | <0.1% | History |
| ADAGAdagene Inc. | ADS | 263,176 | $2.12M | <0.1% | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,729,402 | $1.58M | <0.1% | History |
| AUGXAugmedix, Inc. | COM | 88,363 | $278.0K | <0.1% | History |
| SVASinovac Biotech Ltd | SHS | 2,839,500 | – | – | History |